Apheresis Devices Market by Product and Geography - Forecast and Analysis 2020-2024

SKU ID :TNV-14208418 | Published Date: 19-Nov-2019 | No. of pages: 151
PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Value chain analysis • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2019 • Market size and forecast 2019-2024 • Market outlook PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Systems - Market size and forecast 2019-2024 • Consumables - Market size and forecast 2019-2024 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2019-2024 • Europe - Market size and forecast 2019-2024 • Asia - Market size and forecast 2019-2024 • ROW - Market size and forecast 2019-2024 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Technological advances • Business strategies • Growth in new indications for plasma products PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Asahi Kasei Corp. • B. Braun Melsungen AG • Cerus Corp. • Fresenius Medical Care AG & Co. KGaA • Haemonetics Corp. • HemaCare Corp. • Kaneka Corp. • Kawasumi Laboratories Inc. • Nikkiso Co. Ltd. • Terumo Corp. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global healthcare equipment market Exhibit 03: Segments of global healthcare equipment market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2019 Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions) Exhibit 09: Global market: Year-over-year growth 2020-2024 (%) Exhibit 10: Five forces analysis 2019 Exhibit 11: Five forces analysis 2024 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2019 Exhibit 18: Product - Market share 2019-2024 (%) Exhibit 19: Comparison by product Exhibit 20: Systems - Market size and forecast 2019-2024 ($ millions) Exhibit 21: Systems - Year-over-year growth 2020-2024 (%) Exhibit 22: Consumables - Market size and forecast 2019-2024 ($ millions) Exhibit 23: Consumables - Year-over-year growth 2020-2024 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2019-2024 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions) Exhibit 29: North America - Year-over-year growth 2020-2024 (%) Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions) Exhibit 31: Europe - Year-over-year growth 2020-2024 (%) Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions) Exhibit 33: Asia - Year-over-year growth 2020-2024 (%) Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions) Exhibit 35: ROW - Year-over-year growth 2020-2024 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Product launch details and market impact analysis Exhibit 39: Impact of drivers and challenges Exhibit 40: Business strategies and their market impact analysis Exhibit 41: Vendor landscape Exhibit 42: Landscape disruption Exhibit 43: Vendors covered Exhibit 44: Vendor classification Exhibit 45: Market positioning of vendors Exhibit 46: Asahi Kasei Corp. - Vendor overview Exhibit 47: Asahi Kasei Corp. - Product segments Exhibit 48: Asahi Kasei Corp. - Organizational developments Exhibit 49: Asahi Kasei Corp. - Geographic focus Exhibit 50: Asahi Kasei Corp. - Segment focus Exhibit 51: Asahi Kasei Corp. - Key offerings Exhibit 52: Asahi Kasei Corp. - Key customers Exhibit 53: B. Braun Melsungen AG - Vendor overview Exhibit 54: B. Braun Melsungen AG - Business segments Exhibit 55: B. Braun Melsungen AG - Organizational developments Exhibit 56: B. Braun Melsungen AG - Geographic focus Exhibit 57: B. Braun Melsungen AG - Segment focus Exhibit 58: B. Braun Melsungen AG - Key offerings Exhibit 59: B. Braun Melsungen AG - Key customers Exhibit 60: Cerus Corp. - Vendor overview Exhibit 61: Cerus Corp. - Business segments Exhibit 62: Cerus Corp. - Organizational developments Exhibit 63: Cerus Corp. - Geographic focus Exhibit 64: Cerus Corp. - Key offerings Exhibit 65: Cerus Corp. - Key customers Exhibit 66: Fresenius Medical Care AG & Co. KGaA - Vendor overview Exhibit 67: Fresenius Medical Care AG & Co. KGaA - Business segments Exhibit 68: Fresenius Medical Care AG & Co. KGaA - Organizational developments Exhibit 69: Fresenius Medical Care AG & Co. KGaA - Geographic focus Exhibit 70: Fresenius Medical Care AG & Co. KGaA - Segment focus Exhibit 71: Fresenius Medical Care AG & Co. KGaA - Key offerings Exhibit 72: Fresenius Medical Care AG & Co. KGaA - Key customers Exhibit 73: Haemonetics Corp. - Vendor overview Exhibit 74: Haemonetics Corp. - Business segments Exhibit 75: Haemonetics Corp. - Organizational developments Exhibit 76: Haemonetics Corp. - Geographic focus Exhibit 77: Haemonetics Corp. - Segment focus Exhibit 78: Haemonetics Corp. - Key offerings Exhibit 79: Haemonetics Corp. - Key customers Exhibit 80: HemaCare Corp. - Vendor overview Exhibit 81: HemaCare Corp. - Product segments Exhibit 82: HemaCare Corp. - Organizational developments Exhibit 83: HemaCare Corp. - Key offerings Exhibit 84: HemaCare Corp. - Key customers Exhibit 85: Kaneka Corp. - Vendor overview Exhibit 86: Kaneka Corp. - Business segments Exhibit 87: Kaneka Corp. - Organizational developments Exhibit 88: Kaneka Corp. - Geographic focus Exhibit 89: Kaneka Corp. - Segment focus Exhibit 90: Kaneka Corp. - Key offerings Exhibit 91: Kaneka Corp. - Key customers Exhibit 92: Kawasumi Laboratories Inc. - Vendor overview Exhibit 93: Kawasumi Laboratories Inc. - Business segments Exhibit 94: Kawasumi Laboratories Inc. - Key offerings Exhibit 95: Kawasumi Laboratories Inc. - Key customers Exhibit 96: Nikkiso Co. Ltd. - Vendor overview Exhibit 97: Nikkiso Co. Ltd. - Business segments Exhibit 98: Nikkiso Co. Ltd. - Geographic focus Exhibit 99: Nikkiso Co. Ltd. - Segment focus Exhibit 100: Nikkiso Co. Ltd. - Key offerings Exhibit 101: Nikkiso Co. Ltd. - Key customers Exhibit 102: Terumo Corp. - Vendor overview Exhibit 103: Terumo Corp. - Business segments Exhibit 104: Terumo Corp. - Organizational developments Exhibit 105: Terumo Corp. - Geographic focus Exhibit 106: Terumo Corp. - Segment focus Exhibit 107: Terumo Corp. - Key offerings Exhibit 108: Terumo Corp. - Key customers Exhibit 109: Validation techniques employed for market sizing Exhibit 110: Definition of market positioning of vendors
Asahi Kasei Corp., B. Braun Melsungen AG, Cerus Corp., Fresenius Medical Care AG & Co. KGaA, Haemonetics Corp., HemaCare Corp., Kaneka Corp., Kawasumi Laboratories Inc., Nikkiso Co. Ltd., and Terumo Corp.
  • PRICE
  • $2500
    $4000

Our Clients